Diagnosis of pancreatic solid lesions by ultrasound endoscopy fine-needle biopsy with Franseen needles: macroscopic on-site (MOSE) versus rapid on-site (ROSE) evaluation. Is the pathologist necessary in the endoscopy suite?
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S154
DOI: 10.1055/s-0044-1783026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von E. Pijoan Comas und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
The evaluation of biopsy samples obtained with fine-needle biopsy (FNB-EUS) using Franseen needles by ultrasound endoscopy by endoscopist (Macroscopic On-Site Evaluation: MOSE) improves the diagnostic accuracy of pancreatic solid lesions. The achievement of macroscopic visible core (MVC)>4mm has a high diagnostic accuracy with MOSE.
Aim
To compare diagnostic accuracy of Rapid On-Site Evaluation (ROSE) and MOSE by endoscopist in pancreatic solid lesions.
Methods
Prospective bicentric study, consecutive recruitment of patients with pancreatic solid lesions in 2 general hospitals (MOSE was performed in hospital A and ROSE in hospital B). Franseen needles were used (Adquire, Boston Scientific). We evaluated: 1) diagnostic achievement and accuracy (including sensitivity, specificity, positive predictive value and negative predictive value) in solid pancreatic lesions; 2) MVC>4mm acquisition; and 3) number of needle passes needed with MOSE vs ROSE.
Results
A total of 132 patients were included (33 women, 68 men, median age 68,2±1,025). MOSE was performed in 90 (68.2%) and ROSE in 42 (31.8%); in 110 (83.3%) malign and 22 (16.7%) benign pancreatic solid lesions. Correct diagnosis by EUS-FNB was achieved in 89.4% patients (with MOSE 88.8%; and ROSE 92.9%; p=0.54). Sensitivity was 100%, specificity 89%, PPV 81.3% and NPV 100% (with MOSE: sensitivity 100%, specificity 87.5%, PPV 88.8% and NPV 100%; with ROSE: sensitivity 100%, specificity 92.1%, PPV 92.6% and NPV 100%). MVC>4mm was obtained in 72.7% (71.1% in MOSE, 76.2% in ROSE, p=0.67). There were no statistically significant differences in diagnosis achievement between MVC>4mm and
Zitieren
APA
Comas, E. P., Gomez, D. V., Velasco, N. Z., García, A. L. V., Miranda, M. A., Monclus, N. T., Francesch, M. F., Ballester-Clau, R., Rubinat, M. P. D., & Lladó, F. G. (2024). Diagnosis of pancreatic solid lesions by ultrasound endoscopy fine-needle biopsy with Franseen needles: macroscopic on-site (MOSE) versus rapid on-site (ROSE) evaluation. Is the pathologist necessary in the endoscopy suite?. Endoscopy, 56(S 02 S 02), S154. https://doi.org/10.1055/s-0044-1783026
Vancouver
Comas EP, Gomez DV, Velasco NZ, García ALV, Miranda MA, Monclus NT, et al. Diagnosis of pancreatic solid lesions by ultrasound endoscopy fine-needle biopsy with Franseen needles: macroscopic on-site (MOSE) versus rapid on-site (ROSE) evaluation. Is the pathologist necessary in the endoscopy suite?. Endoscopy. 2024;56(S 02 S 02):S154. doi:10.1055/s-0044-1783026
BibTeX
@article{Comas2024,
author = {Comas, E. Pijoan and Gomez, D. Vazquez and Velasco, N. Zaragoza and García, A. L. Vargas and Miranda, M. Alburquerque and Monclus, N. Torres and Francesch, M. Figa and Ballester-Clau, R. and Rubinat, M. Planella De and Lladó, F. González-Huix},
title = {Diagnosis of pancreatic solid lesions by ultrasound endoscopy fine-needle biopsy with Franseen needles: macroscopic on-site (MOSE) versus rapid on-site (ROSE) evaluation. Is the pathologist necessary in the endoscopy suite?},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S154},
doi = {10.1055/s-0044-1783026}
}
EUVIMED